Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A
Clinical trial NCT06224907 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06224907
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2025-04-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.